CLINICAL_TRIALS
research
· 2008-01-25
Clinical Trial Update: MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant [Phase 2, Phase 3]
Summary
An update on the MIST II PFO-Migraine trial evaluating the BioSTAR bioabsorbable septal repair implant in patients with migraine (with aura) and patent foramen …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NMT Medical | Conditions: Migraine, Aura | Phase 2, Phase 3 | Status: UNKNOWN